NVDA
NVIDIA
-- 130.390 TSLA
Tesla
-- 479.860 QUBT
Quantum Computing
-- 16.790 AVGO
Broadcom
-- 240.230 RGTI
Rigetti Computing
-- 11.1300 
Xaciato to Market
$Dare Bioscience (DARE.US)$ So now that the FDA has approved Xaciato, the company has said they are working on finding a partnership to bring it to market. However, many of those potential partners are heavy with cash. Some believe there is a potential that one of these companies could decide to just buy DARÈ rather than partner with them. $SPDR S&P Biotech ETF (XBI.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
student otg : no idea buddy. But if a buyout were to occur this thing could go from 2 up to God only knows. I know there has been speculation that Bayer could potentially be in the mix so...think about that.
TerpsLife OP student otg : yeah, we don't know for sure either way. Just gaging popular opinion. Bayer does seem like a great fit for either option.
robbie1945 TerpsLife OP : Sorry to comment so late but I wonder if any of the agreements due to grants by gate foundation to make the drugs low cost and affordable would supersede any potential buyout if there were any clauses where company cannot be bought out, etc. Therefore I think a partnership is way more likely, if anything though we should expect more institutional ownership here this coming year, will increase stock price and lock up float.
TerpsLife OP robbie1945 : I doubt there are any stipulations in the grant that prevent buyout, that would be uncommon. I tried to see if that was the case and didn't see Amy mention of it in PR or the subsequent 10q.